Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)

SHE:002524 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	-2.72	-19.5	-174.65	9.26	-78.22	36.93
Depreciation & Amortization	85.56	91.35	95.76	100.33	100.02	106.39
Other Amortization	9.03	10.42	11.15	14.54	14.24	17.13
Loss (Gain) From Sale of Assets	-0.94	0.2	-5.02	-1.7	-1.04	-7.2
Asset Writedown & Restructuring Costs	3.01	1.62	134.67	1.35	138.72	5.78
Loss (Gain) From Sale of Investments	-25.2	-9.41	-14.77	-0.79	20.51	-80.62
Provision & Write-off of Bad Debts	-0.43	-0.43	0.79	2.65	1.77	-5.76
Other Operating Activities	31.66	34.36	39.2	38.75	35.25	38.59
Change in Accounts Receivable	19.77	-15.49	33.4	-54.02	48.7	-23.57
Change in Inventory	8.27	-1.89	3.05	27.71	-8.7	16.88
Change in Accounts Payable	5.04	40.15	-68.26	-92.22	-146.72	35.77
Change in Other Net Operating Assets	-6.25	-4.56	7.21	4.23	2.01	6.25
Operating Cash Flow	126.18	124.73	69.07	38.91	124.33	145.37
Operating Cash Flow Growth	110.74%	80.57%	77.54%	-68.71%	-14.48%	-6.20%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-20.97	-29.04	-25.75	-23.42	-40.71	-52.47
Sale of Property, Plant & Equipment	1.85	1.33	7.13	1.89	1.81	3.54
Cash Acquisitions	-	-	-	-	-	-16.2
Divestitures	20.07	-	-	-	-	100.1
Investment in Securities	6.42	12.61	37.45	2.46	-62.19	-33.92
Other Investing Activities	0.1	0.1	0.43	4.73	0.48	0.19
Investing Cash Flow	7.46	-15	19.25	-14.35	-100.62	1.24

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Long-Term Debt Issued	-	357.9	414.55	447.08	290.94	259.17
Long-Term Debt Repaid	-	-461.43	-489.61	-431.2	-303.07	-526.15
Net Debt Issued (Repaid)	-129.47	-103.53	-75.07	15.88	-12.13	-266.98
Issuance of Common Stock	-	-	0.97	24.81	0.46	77.8
Repurchase of Common Stock	-9.84	-9.84	-0.43	-12.28	-3.06	-22.72
Common Dividends Paid	-13.48	-15.08	-16.26	-	-11.89	-16.52
Other Financing Activities	7.88	-0.39	-1.12	-42.34	14.87	18.57
Financing Cash Flow	-144.91	-128.85	-91.9	-13.93	-11.75	-209.85

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Cash Flow	-11.28	-19.12	-3.57	10.63	11.96	-63.23

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	105.21	95.69	43.32	15.48	83.61	92.91
Free Cash Flow Growth	298.60%	120.89%	179.81%	-81.48%	-10.00%	0.01%
Free Cash Flow Margin	12.54%	10.81%	4.85%	1.44%	10.90%	8.89%
Free Cash Flow Per Share	0.13	0.20	0.08	0.03	0.16	0.18
Levered Free Cash Flow	85.73	68.87	19.82	-8.34	-197.02	59.6
Unlevered Free Cash Flow	106.96	90.09	43.81	15.88	-174.31	83.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Interest Paid	-	-	-	14.5	-	-
Cash Income Tax Paid	38.57	25.62	24.29	31.8	23.88	30.74
Change in Working Capital	26.2	16.12	-18.04	-125.48	-106.93	34.13

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error